IL10 and campylobacteriosis: Given that murine FMT treatment could effectively dampen pathogen-induced apoptotic epithelial and pro-inflammatory immune responses in the large intestines of C. jejuni-infected microbiota-depleted, as well as of “humanized”, IL-10−/− mice [27,31], these findings collectively provide strong evidence that microbiota modifications by pre- or probiotics, for instance, might open novel avenues for future treatment strategies in the combat of campylobacteriosis in humans.